PE20081252A1 - Derivados de espiro-piperidina - Google Patents
Derivados de espiro-piperidinaInfo
- Publication number
- PE20081252A1 PE20081252A1 PE2007001736A PE2007001736A PE20081252A1 PE 20081252 A1 PE20081252 A1 PE 20081252A1 PE 2007001736 A PE2007001736 A PE 2007001736A PE 2007001736 A PE2007001736 A PE 2007001736A PE 20081252 A1 PE20081252 A1 PE 20081252A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- halogen
- alcoxy
- spyro
- indol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Psychiatry (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Pregnancy & Childbirth (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
SE REFIERE A COMPUESTOS DERIVADOS DE ESPIRO-PIPERIDINA DE FORMULA (I) DONDE X ES C=O, CH2, O, NR7, EN DONDE R7 ES H O ALQUILO(C1-C6); Y ES O, CH2, C=O; O X-Y ES -C=C- O -CH2-CH2-; R1 ES H, ALQUILO(C1-C6) OPCIONALMENTE SUSTITUIDO CON CN U OH, O -(ALQUILENO(C1-C6))-C(O)-NRaRb, DONDE Ra Y Rb SON CADA UNO H, ALQUILO(C1-C6), ENTRE OTROS; R2 ES H, ALQUILO(C1-C6), ALCOXI(C1-C6), ENTRE OTROS; R3 ES H, HALOGENO O ALQUILO(C1-C6); R4 ES H, HALOGENO, ALQUILO(C1-C6), ALCOXI(C1-6), ENTRE OTROS; R5 ES H, HALOGENO, ALCOXI(C1-C6), ENTRE OTROS; R6 ES H, NITRO, CN, HALOGENO, ENTRE OTROS; R8, R9, R10 Y R11 SON CADA UNO H, HALOGENO, ALQUILO(C1-C6), ALCOXI(C1-C6), ENTRE OTROS. SON COMPUESTOS PREFERIDOS: {5-CLORO-2-[(3-OXO-1'H,3H-ESPIRO[2-BENZOFURANO-1,4'-PIPERIDIN]-1'-IL)CARBONIL]-1H-INDOL-7-IL}ACETONITRILO, 2-{5-CLORO-2-[(3-OXO-1'H,3H-ESPIRO[2-BENZOFURANO-1,4'-PIPERIDIN]-1'-IL)CARBONIL]-1H-INDOL-1-IL}-N,N-DIMETILACETAMIDA, 1'-[(5-CLORO-1H-INDOL-2-IL)CARBONIL]-3H-ESPIRO[2-BENZOFURANO-1,4'-PIPERIDIN]-3-ONA, ENTRE OTROS. SE REFIERE TAMBIEN A UN PROCEDIMIENTO DE PREPARACION Y A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON ANTAGONISTAS DEL RECEPTOR DE LA VASOPRESINA V1a SIENDO UTILES EN EL TRATAMIENTO DE ANSIEDAD, DEPRESION, DISMENORREA, FALLO CARDIACO CRONICO
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06125634 | 2006-12-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20081252A1 true PE20081252A1 (es) | 2008-09-04 |
Family
ID=39295880
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2007001736A PE20081252A1 (es) | 2006-12-07 | 2007-12-06 | Derivados de espiro-piperidina |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US20080139554A1 (es) |
| EP (1) | EP2102207B1 (es) |
| JP (1) | JP2010511661A (es) |
| KR (1) | KR101050568B1 (es) |
| CN (1) | CN101547923A (es) |
| AR (1) | AR064135A1 (es) |
| AT (1) | ATE469900T1 (es) |
| AU (1) | AU2007328995B2 (es) |
| BR (1) | BRPI0720004A2 (es) |
| CA (1) | CA2670674A1 (es) |
| CL (1) | CL2007003482A1 (es) |
| DE (1) | DE602007006990D1 (es) |
| ES (1) | ES2344131T3 (es) |
| IL (1) | IL198544A (es) |
| MX (1) | MX2009005504A (es) |
| NO (1) | NO20091830L (es) |
| PE (1) | PE20081252A1 (es) |
| RU (1) | RU2009119394A (es) |
| TW (1) | TW200838518A (es) |
| WO (1) | WO2008068185A1 (es) |
| ZA (1) | ZA200903496B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008077810A2 (en) | 2006-12-22 | 2008-07-03 | F. Hoffmann-La Roche Ag | Spiro-piperidine derivatives |
| EA019601B1 (ru) | 2008-04-29 | 2014-04-30 | Новартис Аг | Производные спироиндола, предназначенные для лечения паразитарных заболеваний |
| SG11201703604VA (en) * | 2014-11-14 | 2017-06-29 | Hoffmann La Roche | Spiro-thiazolones |
| EP3414247B1 (en) * | 2016-02-08 | 2021-04-21 | F. Hoffmann-La Roche AG | Spiroindolinones as ddr1 inhibitors |
| KR102765806B1 (ko) * | 2017-09-05 | 2025-02-10 | 블랙손 테라퓨틱스, 인크. | 바소프레신 수용체 길항제 및 그와 관련된 제품 및 방법 |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3370091A (en) * | 1964-06-15 | 1968-02-20 | Hoffmann La Roche | 2 aminobenzhydrylhalides |
| US3531467A (en) * | 1966-12-23 | 1970-09-29 | Hoffmann La Roche | Process for the preparation of 2,3,4,5-tetrahydro - 5 - aryl - 1h - 1,4 - benzodiazepine derivatives |
| US4209625A (en) * | 1977-04-21 | 1980-06-24 | American Hoechst Corporation | Spiro[indoline-3,4'-piperidine]s |
| DE3818830A1 (de) * | 1988-06-03 | 1989-12-14 | Boehringer Mannheim Gmbh | Bicyclische carboxamide, verfahren zu ihrer herstellung, deren vorstufen, und diese verbindungen enthaltende arzneimittel |
| EP0450761A1 (en) | 1990-03-02 | 1991-10-09 | Merck & Co. Inc. | Spirocyclic oxytocin antagonists |
| DK78692D0 (da) | 1992-06-12 | 1992-06-12 | Lundbeck & Co As H | Dimere piperidin- og piperazinderivater |
| JPH08502474A (ja) | 1992-10-07 | 1996-03-19 | メルク エンド カンパニー インコーポレーテッド | トコリティックオキシトシンレセプターアンタゴニスト |
| US5670509A (en) * | 1993-09-27 | 1997-09-23 | Merck & Co., Inc. | Tocolytic oxytocin receptor antagonists |
| IT1271026B (it) | 1994-10-21 | 1997-05-26 | Isagro Ricerca Srl | Derivati dell'acido b-amminopropionico ad attivita' fungicida |
| US5576321A (en) | 1995-01-17 | 1996-11-19 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
| CN1208412A (zh) | 1995-12-14 | 1999-02-17 | 麦克公司 | 促性腺激素释放激素拮抗剂 |
| GB9601724D0 (en) | 1996-01-29 | 1996-03-27 | Merck Sharp & Dohme | Therapeutic agents |
| US6166209A (en) | 1997-12-11 | 2000-12-26 | Hoffmann-La Roche Inc. | Piperidine derivatives |
| CO5150201A1 (es) | 1998-09-07 | 2002-04-29 | Hoffmann La Roche | Derivados de piperidina |
| TWI279402B (en) | 1999-08-20 | 2007-04-21 | Banyu Pharma Co Ltd | Spiro compounds having NPY antagonistic activities and agents containing the same |
| GB0003397D0 (en) | 2000-02-14 | 2000-04-05 | Merck Sharp & Dohme | Therapeutic agents |
| CN1174979C (zh) | 2000-05-12 | 2004-11-10 | 索尔瓦药物有限公司 | 哌嗪和哌啶化合物 |
| US7109229B2 (en) | 2000-09-29 | 2006-09-19 | Eli Lilly And Company | Methods and compounds for treating proliferative diseases |
| BR0214455A (pt) | 2001-11-27 | 2004-11-03 | Hoffmann La Roche | Derivados benzotiazol |
| FR2833948B1 (fr) | 2001-12-21 | 2004-02-06 | Sod Conseils Rech Applic | Nouveaux derives de benzimidazole et leur utilisation en tant que medicament |
| US20040152741A1 (en) | 2002-09-09 | 2004-08-05 | Nps Allelix Corporation | Arylglycine derivatives and their use as glycine transport inhibitors |
| AU2003263155A1 (en) | 2002-09-20 | 2004-04-08 | H. Lundbeck A/S | Method for manufacture of dihydroisobenzofuran derivatives |
| MXPA05003948A (es) | 2002-10-17 | 2005-06-17 | Amgen Inc | Derivados de bencimidazol y su uso como ligandos de receptor vaniloide. |
| AU2003215549A1 (en) | 2003-02-03 | 2004-08-30 | Janssen Pharmaceutica N.V. | Mercaptoimidazoles as ccr2 receptor antagonists |
| US7244852B2 (en) * | 2003-02-27 | 2007-07-17 | Abbott Laboratories | Process for preparing 2-methylpyrrolidine and specific enantiomers thereof |
| EP1615698B1 (en) * | 2003-04-11 | 2010-09-29 | High Point Pharmaceuticals, LLC | New amide derivatives and pharmaceutical use thereof |
| US7504506B2 (en) | 2003-11-04 | 2009-03-17 | Elixir Pharmaceuticals, Inc. | Therapeutic compounds and uses thereof |
| EP1701959A1 (en) * | 2003-12-22 | 2006-09-20 | Pfizer Limited | Triazole derivatives as vasopressin antagonists |
| CA2546147A1 (en) | 2003-12-23 | 2005-07-14 | Arena Pharmaceuticals, Inc. | Novel spiroindoline or spiroisoquinoline compounds, methods of use and compositions thereof |
| GB0400700D0 (en) * | 2004-01-13 | 2004-02-18 | Pfizer Ltd | Compounds useful in therapy |
| CN1993323B (zh) | 2004-08-05 | 2011-04-20 | 霍夫曼-拉罗奇有限公司 | 吲哚，吲唑或二氢吲哚衍生物 |
| EP1802623A1 (en) | 2004-10-12 | 2007-07-04 | Novo Nordisk A/S | 11beta-hydroxysteroid dehydrogenase type 1 active spiro compounds |
| WO2006041171A1 (ja) * | 2004-10-13 | 2006-04-20 | Sony Corporation | 再生装置、撮像装置、画面表示方法およびユーザインターフェース |
| JP2008540633A (ja) | 2005-05-18 | 2008-11-20 | ファイザー・リミテッド | バソプレッシン拮抗薬としての１，２，４−トリアゾール誘導体 |
| US8190027B2 (en) * | 2006-07-12 | 2012-05-29 | Tellabs Operations, Inc. | Multifunctional and reconfigurable optical node and optical network |
| DE602006004997D1 (de) * | 2005-07-14 | 2009-03-12 | Hoffmann La Roche | Indol-3-carbonyl-spiro-piperidinderivate als antagonisten des v1a-rezeptors |
| WO2007028638A1 (en) | 2005-09-09 | 2007-03-15 | Euro-Celtique S.A. | Fused and spirocycle compounds and the use thereof |
| WO2008077810A2 (en) * | 2006-12-22 | 2008-07-03 | F. Hoffmann-La Roche Ag | Spiro-piperidine derivatives |
| EP2125827B1 (en) * | 2006-12-29 | 2010-11-03 | F. Hoffmann-La Roche AG | Azaspiro derivatives |
| ATE536356T1 (de) * | 2007-01-12 | 2011-12-15 | Hoffmann La Roche | Spiropiperidin-glycinamid-derivate |
-
2007
- 2007-11-29 AT AT07847502T patent/ATE469900T1/de active
- 2007-11-29 WO PCT/EP2007/062985 patent/WO2008068185A1/en not_active Ceased
- 2007-11-29 AU AU2007328995A patent/AU2007328995B2/en not_active Expired - Fee Related
- 2007-11-29 MX MX2009005504A patent/MX2009005504A/es active IP Right Grant
- 2007-11-29 CN CNA2007800448317A patent/CN101547923A/zh active Pending
- 2007-11-29 DE DE602007006990T patent/DE602007006990D1/de active Active
- 2007-11-29 BR BRPI0720004-8A patent/BRPI0720004A2/pt not_active IP Right Cessation
- 2007-11-29 KR KR1020097011665A patent/KR101050568B1/ko not_active Expired - Fee Related
- 2007-11-29 EP EP07847502A patent/EP2102207B1/en not_active Not-in-force
- 2007-11-29 CA CA002670674A patent/CA2670674A1/en not_active Abandoned
- 2007-11-29 RU RU2009119394/04A patent/RU2009119394A/ru not_active Application Discontinuation
- 2007-11-29 ES ES07847502T patent/ES2344131T3/es active Active
- 2007-11-29 JP JP2009539707A patent/JP2010511661A/ja active Pending
- 2007-11-30 US US11/947,967 patent/US20080139554A1/en not_active Abandoned
- 2007-11-30 US US11/947,934 patent/US20080146568A1/en not_active Abandoned
- 2007-11-30 US US11/947,953 patent/US8202993B2/en not_active Expired - Fee Related
- 2007-12-04 CL CL200703482A patent/CL2007003482A1/es unknown
- 2007-12-04 TW TW096146114A patent/TW200838518A/zh unknown
- 2007-12-05 AR ARP070105426A patent/AR064135A1/es unknown
- 2007-12-06 PE PE2007001736A patent/PE20081252A1/es not_active Application Discontinuation
-
2009
- 2009-05-04 IL IL198544A patent/IL198544A/en not_active IP Right Cessation
- 2009-05-11 NO NO20091830A patent/NO20091830L/no not_active Application Discontinuation
- 2009-05-20 ZA ZA200903496A patent/ZA200903496B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2009119394A (ru) | 2011-01-20 |
| ZA200903496B (en) | 2010-03-31 |
| ES2344131T3 (es) | 2010-08-18 |
| KR101050568B1 (ko) | 2011-07-19 |
| US20080139554A1 (en) | 2008-06-12 |
| TW200838518A (en) | 2008-10-01 |
| MX2009005504A (es) | 2009-06-03 |
| CA2670674A1 (en) | 2008-06-12 |
| EP2102207A1 (en) | 2009-09-23 |
| AR064135A1 (es) | 2009-03-18 |
| AU2007328995A1 (en) | 2008-06-12 |
| EP2102207B1 (en) | 2010-06-02 |
| US8202993B2 (en) | 2012-06-19 |
| AU2007328995B2 (en) | 2012-04-26 |
| NO20091830L (no) | 2009-07-06 |
| US20080139553A1 (en) | 2008-06-12 |
| US20080146568A1 (en) | 2008-06-19 |
| IL198544A0 (en) | 2010-02-17 |
| DE602007006990D1 (de) | 2010-07-15 |
| CN101547923A (zh) | 2009-09-30 |
| BRPI0720004A2 (pt) | 2013-12-17 |
| KR20090079255A (ko) | 2009-07-21 |
| JP2010511661A (ja) | 2010-04-15 |
| IL198544A (en) | 2012-06-28 |
| ATE469900T1 (de) | 2010-06-15 |
| CL2007003482A1 (es) | 2008-07-04 |
| WO2008068185A1 (en) | 2008-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20081844A1 (es) | DERIVADOS DE INDOL-3-IL-CARBONIL-AZASPIROPIPERIDINA COMO ANTAGONISTAS DEL RECEPTOR V1a | |
| PE20081851A1 (es) | Derivados de espiropiperidina-glicinamida | |
| PE20081252A1 (es) | Derivados de espiro-piperidina | |
| CO5700754A2 (es) | Derivados de piperazina y su uso en el tratamiento de enfermedades neurologicas y psiquiatricas | |
| PE20081489A1 (es) | Derivados de espiro-piperidina | |
| AR051090A1 (es) | Derivados heterociclicos y su uso como inhibidores de la estearoil-coa desaturasa | |
| PE20030848A1 (es) | Compuestos de espiropiperidina n-sustituidos como ligandos para el receptor orl-1 | |
| AR051095A1 (es) | Derivados heterociclicos y su uso comoinhibidores de la estearoil-coa desaturasa | |
| PE20020062A1 (es) | 5-AMINO-PIRAZOLO-[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PIRIMIDINA COMO ANTAGONISTAS RECEPTORES DE ADENOSINA A2a | |
| AR051092A1 (es) | Derivados heterociclicos y su uso como inhibidores de la estearoil-coa | |
| AR070207A1 (es) | Derivados biciclicos de carboxamidas aza- biciclicas su preparacion y su aplicacion terapeutica | |
| PE20081164A1 (es) | Nuevos compuestos 521 | |
| PE20120031A1 (es) | Compuestos aril metil benzoquinazolinona como moduladores alostericos positivos del receptor m1 | |
| AR051091A1 (es) | Derivados heterociclicos y su uso como inhibidores de la estearoil-coa desaturasa | |
| PE20030847A1 (es) | Aza-arilpiperazinas como ligandos del receptor 5ht2 | |
| PE20080671A1 (es) | DERIVADOS DE 2-ARIL-6-FENIL-IMIDAZO[1,2-a]PIRIDINAS, SU PREPARACION Y SU APLICACION EN TERAPEUTICA | |
| ES2179490T3 (es) | Derivados de 1,2,4-triazolo(3,4-a)ftalazina sustituidos como ligandos de gaba alfa 5. | |
| RU2009125024A (ru) | Соединения замещенных диазепанов в качестве антагонистов орексиновых рецепторов | |
| AR076860A1 (es) | Derivados de 7-aril- 1,2,4-triazolo[4,3-a]piridina moduladores alostericos positivos de receptores mglur2, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de trastornos neurologicos y siquiatricos. | |
| AR047744A1 (es) | Compuestos de triazol y su uso como antagonistas del receptor de glutamato metabotropico | |
| AR060318A1 (es) | Isoindolonas potenciadoras de receptores metabotropicos de glutamato, composiciones farmaceuticas que las comprenden y el uso de las mismas en la fabricacion de un medicamento para el tratamiento de trastornos neurologicos y psiquiatricos. | |
| PE20091884A1 (es) | Antagonistas de cgrp seleccionados, procedimiento para su preparacion, asi como su uso como medicamento | |
| RU2004126612A (ru) | Хиназолиновые соединения | |
| MX2009009121A (es) | Aminoamidas como antagonistas de orexina. | |
| PE20091818A1 (es) | DERIVADOS POLISUSTITUIDOS DE 2-ARIL-6-FENIL-IMIDAZO[1,2-a] PIRIDINAS, SU PREPARACION Y SU APLICACION EN TERAPEUTICA |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |